{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:16:29Z","timestamp":1790223389938,"version":"4.1.0"},"reference-count":28,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T00:00:00Z","timestamp":1755129600000},"content-version":"unspecified","delay-in-days":44,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017759","name":"Childhood Arthritis and Rheumatology Research Alliance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017759","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Samara Jan Turkel Center"},{"DOI":"10.13039\/100000980","name":"Arthritis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000980","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIH\/NIAMS","award":["T32 AR007530"],"award-info":[{"award-number":["T32 AR007530"]}]},{"DOI":"10.13039\/100006093","name":"PCORI","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100006093","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["U01 DP006701"],"award-info":[{"award-number":["U01 DP006701"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001009","name":"Bristol Myers Squibb Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Lupus Sci Med"],"accepted":{"date-parts":[[2025,7,26]]},"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Using data from participants with paediatric SLE (pSLE) in the Childhood Arthritis and Rheumatology Research Alliance Registry, we aimed to: (1) describe 2-year disease activity trajectories, measured by the SLE Disease Activity Index 2000 (SLEDAI 2K); (2) identify characteristics associated with each trajectory and (3) assess achievement of lupus low disease activity state (LLDAS) and associated baseline characteristics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Participants were diagnosed with pSLE within 12 months of baseline visit. Baseline sociodemographic, clinical and treatment characteristics were included in latent trajectory analyses. Associations between patient characteristics with trajectory groups and LLDAS were analysed with multinomial generalised logistic regression modelling.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>1002 patients were screened; 553 were included for SLEDAI 2K and 269 for LLDAS analyses. SLEDAI 2K trajectories included (T1) low and stable, (T2) high and decreasing, (T3) intermediate and stable. In multinomial generalised logistic regression, baseline SLEDAI 2K score and insurance type were significantly associated with trajectories. 51% (136\/269) of patients achieved LLDAS at least once in 24 months as compared with 17% (47\/269) at first assessment. LLDAS attainment at both time points was predicted by lower pain interference scores; LLDAS attainment over 24 months was also associated with baseline American College of Rheumatology classification criteria, rituximab use at baseline and highest completed level of parent\/guardian education.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Disease activity trajectories in a pSLE cohort were predicted by baseline SLEDAI 2K and insurance. Only half of the patients achieved LLDAS during the 2-year study period, which was predicted by baseline characteristics including pain interference. The relationship between disease activity and socioeconomic factors and pain warrants further investigation to identify modifiable factors to reduce pSLE disease activity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/lupus-2025-001521","type":"journal-article","created":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T10:15:20Z","timestamp":1755166520000},"page":"e001521","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Disease activity trajectories in paediatric lupus and associations with socioeconomic factors and patient-reported pain"],"prefix":"10.1136","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0300-0586","authenticated-orcid":false,"given":"Siobhan","family":"Case","sequence":"first","affiliation":[{"name":"Brigham and Women\u2019s Hospital, Boston, Massachusetts, USA"},{"name":"Boston Children\u2019s Hospital, Boston, Massachusetts, USA"},{"name":"Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C Larry","family":"Hill","sequence":"additional","affiliation":[{"name":"Duke University Duke Clinical Research Institute, Durham, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Shrader","sequence":"additional","affiliation":[{"name":"Duke University Duke Clinical Research Institute, Durham, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Dennos","sequence":"additional","affiliation":[{"name":"Duke University Duke Clinical Research Institute, Durham, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Phillips","sequence":"additional","affiliation":[{"name":"Duke University Duke Clinical Research Institute, Durham, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1913-6472","authenticated-orcid":false,"given":"Laura Eve","family":"Schanberg","sequence":"additional","affiliation":[{"name":"Pediatrics, Duke University, Durham, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"von Scheven","sequence":"additional","affiliation":[{"name":"Pediatrics, UCSF School of Medicine, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0546-6742","authenticated-orcid":false,"given":"Kamil","family":"Barbour","sequence":"additional","affiliation":[{"name":"National Institutes of Health, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4278-9049","authenticated-orcid":false,"given":"Andrea M","family":"Knight","sequence":"additional","affiliation":[{"name":"Rheumatology, Hospital for Sick Children, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimee","family":"Hersh","sequence":"additional","affiliation":[{"name":"University of Utah Health, Salt Lake City, Utah, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7394-2862","authenticated-orcid":false,"given":"MaryBeth","family":"Son","sequence":"additional","affiliation":[{"name":"Boston Children\u2019s Hospital, Boston, Massachusetts, USA"},{"name":"Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,8,14]]},"reference":[{"key":"2026010700552783000_12.2.e001521.1","first-page":"314","article-title":"Adolescent onset of lupus results in more aggressive disease and worse outcomes: results of a nested matched case-control study within LUMINA, a multiethnic US cohort (LUMINA LVII)","volume":"17","author":"Tucker","year":"2008","journal-title":"Lupus (Los Angel)"},{"key":"2026010700552783000_12.2.e001521.2","doi-asserted-by":"publisher","DOI":"10.1002\/art.23204"},{"key":"2026010700552783000_12.2.e001521.3","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.rdc.2020.07.007","article-title":"Disparities in Childhood-Onset Lupus","volume":"46","author":"Rubinstein","year":"2020","journal-title":"Rheum Dis Clin North Am"},{"key":"2026010700552783000_12.2.e001521.4","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1002\/art.42127","article-title":"Racial Disparities in Renal Outcomes Over Time Among Hospitalized Children With Systemic Lupus Erythematosus","volume":"74","author":"Chang","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"2026010700552783000_12.2.e001521.5","first-page":"1660","article-title":"Principles of pediatric lupus nephritis in a prospective contemporary multi-center cohort","volume":"30","author":"Vazzana","year":"2021","journal-title":"Lupus (Los Angel)"},{"key":"2026010700552783000_12.2.e001521.6","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1002\/acr.23319","article-title":"From Childhood to Adulthood: Disease Activity Trajectories in Childhood-Onset Systemic Lupus Erythematosus","volume":"70","author":"Lim","year":"2018","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2026010700552783000_12.2.e001521.7","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1002\/acr.23199","article-title":"From Childhood to Adulthood: The Trajectory of Damage in Patients With Juvenile-Onset Systemic Lupus Erythematosus","volume":"69","author":"Lim","year":"2017","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2026010700552783000_12.2.e001521.8","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-063675","article-title":"Construct validity of Patient-Reported Outcomes Measurement Information System Paediatric measures in juvenile idiopathic arthritis and systemic lupus erythematosus: cross-sectional evaluation","volume":"13","author":"Weitzman","year":"2023","journal-title":"BMJ Open"},{"key":"2026010700552783000_12.2.e001521.9","first-page":"288","article-title":"Systemic lupus erythematosus disease activity index 2000","volume":"29","author":"Gladman","year":"2002","journal-title":"J Rheumatol"},{"key":"2026010700552783000_12.2.e001521.10","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-207726"},{"key":"2026010700552783000_12.2.e001521.11","doi-asserted-by":"crossref","DOI":"10.1186\/s12969-017-0160-6","article-title":"The new Childhood Arthritis and Rheumatology Research Alliance (CARRA) registry: design, rationale, and characteristics of patients enrolled in the first 12 months","volume":"15","author":"Beukelman","year":"2017","journal-title":"Pediatr Rheumatol Online J"},{"key":"2026010700552783000_12.2.e001521.12","doi-asserted-by":"publisher","DOI":"10.1002\/art.34473"},{"key":"2026010700552783000_12.2.e001521.13","doi-asserted-by":"crossref","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum"},{"key":"2026010700552783000_12.2.e001521.14","doi-asserted-by":"publisher","DOI":"10.7326\/M13-2946"},{"key":"2026010700552783000_12.2.e001521.15","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780390303"},{"key":"2026010700552783000_12.2.e001521.16","doi-asserted-by":"publisher","DOI":"10.1007\/S11136-015-0953-3"},{"key":"2026010700552783000_12.2.e001521.17","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s11136-017-1697-z","article-title":"Assessing responsiveness over time of the PROMIS\u00ae pediatric symptom and function measures in cancer, nephrotic syndrome, and sickle cell disease","volume":"27","author":"Reeve","year":"2018","journal-title":"Qual Life Res"},{"key":"2026010700552783000_12.2.e001521.18","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-013-0581-8"},{"key":"2026010700552783000_12.2.e001521.19","doi-asserted-by":"publisher","DOI":"10.1002\/art.10072"},{"key":"2026010700552783000_12.2.e001521.20","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1093\/rheumatology\/keab915","article-title":"Attainment of low disease activity and remission targets reduces the risk of severe flare and new damage in childhood lupus","volume":"61","author":"Smith","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"2026010700552783000_12.2.e001521.21","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/acr.22650","article-title":"Pain, Fatigue, and Psychological Impact on Health-Related Quality of Life in Childhood-Onset Lupus","volume":"68","author":"Jones","year":"2016","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2026010700552783000_12.2.e001521.22","first-page":"494","article-title":"Predictors of disability in a childhood-onset systemic lupus erythematosus cohort: results from the CARRA Legacy Registry","volume":"27","author":"Hersh","year":"2018","journal-title":"Lupus (Los Angel)"},{"key":"2026010700552783000_12.2.e001521.23","doi-asserted-by":"crossref","DOI":"10.1177\/2055102920977714","article-title":"Understanding patient-provider discordance in adolescents with lupus: The role of pain and antidepressant medication use","volume":"7","author":"Kenney-Riley","year":"2020","journal-title":"Health Psychol Open"},{"key":"2026010700552783000_12.2.e001521.24","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa091"},{"key":"2026010700552783000_12.2.e001521.25","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1093\/rheumatology\/keae575","article-title":"Trajectories of disease evolution upon treatment initiation in systemic lupus erythematosus: results from four clinical trials of belimumab","volume":"64","author":"Parodis","year":"2025","journal-title":"Rheumatology (Oxford)"},{"key":"2026010700552783000_12.2.e001521.26","first-page":"136","article-title":"Extent and characteristics of self-reported pain in patients with systemic lupus erythematosus","volume":"22","author":"Waldheim","year":"2013","journal-title":"Lupus (Los Angel)"},{"key":"2026010700552783000_12.2.e001521.27","doi-asserted-by":"crossref","unstructured":"Kallas R , Li J , Goldman DW , et al . 1114\u2005Trajectory of damage accrual in systemic lupus erythematosus based on ethnicity, socioeconomic factors and comorbidities. Lupus Sci Med 2021;8. doi:10.1136\/lupus-2021-lupus21century.57","DOI":"10.1136\/lupus-2021-lupus21century.57"},{"key":"2026010700552783000_12.2.e001521.28","doi-asserted-by":"crossref","first-page":"109296","DOI":"10.1016\/j.clim.2023.109296","article-title":"PReS-endorsed international childhood lupus T2T task force definition of childhood lupus low disease activity state (cLLDAS)","volume":"250","author":"Smith","year":"2023","journal-title":"Clin Immunol"}],"container-title":["Lupus Science &amp; Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/lupus-2025-001521","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T08:55:46Z","timestamp":1767776146000},"score":1,"resource":{"primary":{"URL":"https:\/\/lupus.bmj.com\/lookup\/doi\/10.1136\/lupus-2025-001521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":28,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,8,14]]},"published-print":{"date-parts":[[2025,7]]}},"alternative-id":["10.1136\/lupus-2025-001521"],"URL":"https:\/\/doi.org\/10.1136\/lupus-2025-001521","relation":{},"ISSN":["2053-8790"],"issn-type":[{"value":"2053-8790","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7]]}}}